Aphria & # 39; hostile & # 39; takeover bids are filled with red flags
Aphria Inc. has been accused of a brief seller for being part of a large network of reverse mergers and marijuana-focused acquisitions intended to enrich insiders at the expense of shareholders.
Aphria has not taken sufficient account of these claims. But now, a close company that has just completed a reverse merger has tried to buy Aphria in a deal that could protect the same investors while not helping other shareholders.
Thursday night, Green Growth Brands Ltd.
GGBXF, + 3.14%
published a general bid for Aphria
APHA, + 12.39%
APHA, + 12.55%
who said it would appreciate the Canadian potty manufacturer of more than $ 2 billion. Getting the $ 2 billion figure requires some fancy math: Green Growth values its own 7-dollar stock, even though they only topped C $ 5 per share on the Canadian Securities Exchange for the first time Friday morning.
Don't miss: Hostile bid for potty producer Aphria comes from the billionaire Ohio family's new American company
Leaders from the two companies had a "friendly" meeting Thursday, where green growth lay its proposal and attempted to secure an exclusive deal, CEO Peter Horvath MarketWatch said in an interview Thursday, although he framed the bid as hostile. "I suppose it's technically a hostile takeover," Horvath said.
Green growth and aphria have a rather long and friendly story for any real hostility that has sprung up now. The Green Growth billionaire, the billionaire Schottenstein family, co-operated with Aphria on a bid to run a medical-marijuana dispensary in Schottenstein's Ohio home in 2017. The two companies have also reported sharing some players, such as Aphria's board member and former Green Growth Board Member Shawn Dym, whom the short seller Hindenburg Research pointed out in a post Friday morning.
Previous research at Aphria by Hindenburg and Quintessential Capital Management led to a large decline in the company's share price, but management has barely addressed any of the specific accusations made by the trader. Aphria is apparently looking to burn his long-standing law firm Stikeman Elliot, who was responsible for advising Aphria about several dubious real estate purchases highlighted by the short seller
Aphria may also have given a clue as to what was found in an internal investigation by removing Chief Executive Vic Neufeld – a main goal of the short seller's theory – from the chairman's role in a small, marked announcement that hit directly after Green Growth published his bid, timing which could lead to the thought that the two actions were coordinated to reduce the influence of the other. Neufeld sits on the advisory board of Green Acre Capital, which took over $ 30 million from Aphria in the first quarter and is an investor in green growth through one of its funds.
A Guide to Pot Holds: What You Need to Know to Invest in Cannabis Companies
Aphria addressed this relationship directly in a statement Friday morning that said the bid "underestimates the company significantly" and that it The proposed transaction carries significant risks for shareholders. Aphria recognized Green Green's Green Growth investment and said that the independent committee considering the takeover bid doesn't have any links to either Green Growth or Green Acre.
While Green Growth's bid could throw Aphria's valuation, it's still worrying for some big investors still holding stakes in Aphria. Green growth was announced through a reverse merger on CSE less than two months ago – it is also listed on this exchange of equity's former name, Xanthic BioPharma Inc. – and an acquisition will in the short term force the aggregate entity to act on it. second-phase Canadian exchange and over-the-counter markets instead of the current Aphria shares, the Toronto Stock Exchange and the New York Stock Exchange. Green Growth recorded modest revenues of about $ 1 million in losses of about half in the last quarter reported and had zero revenue in the same quarter the year before.
Marijuana shares to see: Aphria positions itself as a cheap potty producer
A switch to CSE would mean that many large institutional investors would not be able to own the Aphria share. As MarketWatch has reported, CSE is not floating enough to handle large trades, but has flourished among US-based potters over the past couple of years, as no major stock exchanges would accept listings of companies that obviously violate federal law. And there is an open question about how US investors will be able to take shares in green growth because it will be in violation of federal law.
All of these complications point to an agreement that is unlikely, and perhaps not, to be completed. If Aphria is legit, it is worth more than Green Growth offers; If there are major ethical issues in the company, a related transaction will only temporarily overwrite them. But in the long run they would remain. Either way, this bid does not seem to be a reason why Aphria's stock should be higher.
The Aphria shares got on Friday. US listed shares rose 12.4% during the day, while TSX-listed stock rose 12.6%. The whole sector benefited when the week's trading ended: US-listed shares in Tilray Inc.
TLRY, + 5.73%
jumped 5.7% higher, Aurora Cannabis Inc.
